In many cases, cancer cells develop drug resistance due to over-expression of P-glycoprotein (P-gp, ABCB1), which is an ATP-Binding Cassette (ABC) transporter involved in the efflux of drugs from cells, thereby reducing their intracellular concentrations [1–4]. Here, PGP is linked to cancer.